| peripheral neuropathy |
Damage to the peripheral nervous system, which includes the nerves outside of the brain and spinal cord. Symptoms include pain, numbness, tingling, swelling, and muscle weakness. Peripheral neuropathy may be due to injury, infection, disease (such as diabetes) autoimmune diseases (such as chronic inflammatory demyelinating polyneuropathy) or certain antiretroviral (ARV) drugs. |
|
| peripheral neuropathy |
Damage to the peripheral nervous system, which includes the nerves outside of the brain and spinal cord. Symptoms include pain, numbness, tingling, swelling, and muscle weakness. Peripheral neuropathy may be due to injury, infection, disease (such as diabetes) autoimmune diseases (such as chronic inflammatory demyelinating polyneuropathy) or certain antiretroviral (ARV) drugs. |
|
| Peripheral T-Cell Lymphoma |
PTCL |
sidotatv |
| PICC line |
peripheral-inserted central catheter |
vdengin |
| Peripherally Inserted Central Catheters |
PICC |
|
| PRAR agonist |
peroxisome proliferator-activated receptor-alpha agonist |
'More |
| PRAR-alpha agonist |
peroxisome proliferator-activated receptor-alpha agonist |
'More |
| PPAR-α agonist |
peroxisome proliferator-activated receptor-alpha agonist |
'More |
| PRAR agonist |
peroxisome proliferator-activated receptor-α agonist |
'More |
| PPAR-α agonist |
peroxisome proliferator-activated receptor-α agonist |
'More |
| PRAR-α agonist |
peroxisome proliferator-activated receptor-α agonist |
'More |
| persistent generalized lymphadenopathy (PGL) |
Enlarged lymph nodes (lymphadenopathy) in at least two areas of the body for at least 3 months. In people with HIV, persistent generalized lymphadenopathy (PGL) is associated with early stages of HIV infection and with certain opportunistic infections. |
|
| persistent generalized lymphadenopathy (PGL) |
Enlarged lymph nodes (lymphadenopathy) in at least two areas of the body for at least 3 months. In people with HIV, persistent generalized lymphadenopathy (PGL) is associated with early stages of HIV infection and with certain opportunistic infections. |
|
| peyotl |
peyote |
|
| peyotl |
mescal |
|
| peyotl |
peyote |
|
| pGHD |
pediatric growth hormone deficiency |
Rada0414 |
| Pharmaceutical Inspection Convention |
PIC |
|
| Pharmaceutical Interface Product |
PIP |
|
| pharmacokinetics |
The processes by which a drug is absorbed, distributed, metabolized, and eliminated by the body. |
|
